世界の抗潰瘍薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Antiulcerant Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5591
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、抗潰瘍薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（プロトンポンプ阻害剤、H2受容体拮抗薬、胃粘膜保護薬、抗生物質、制酸剤、プロスタグランジン作動薬）、用途別市場規模（口内潰瘍、胃潰瘍、下腿潰瘍、食道潰瘍、出血性潰瘍、神経障害性潰瘍、静脈うっ血性潰瘍、動脈性（虚血性）潰瘍、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・抗潰瘍薬の市場動向
・企業の競争状況、市場シェア
・抗潰瘍薬の種類別市場規模と予測2016-2027（プロトンポンプ阻害剤、H2受容体拮抗薬、胃粘膜保護薬、抗生物質、制酸剤、プロスタグランジン作動薬）
・抗潰瘍薬の用途別市場規模と予測2016-2027（口内潰瘍、胃潰瘍、下腿潰瘍、食道潰瘍、出血性潰瘍、神経障害性潰瘍、静脈うっ血性潰瘍、動脈性（虚血性）潰瘍、その他）
・抗潰瘍薬の北米市場規模2016-2027（アメリカ、カナダ）
・抗潰瘍薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・抗潰瘍薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・抗潰瘍薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・抗潰瘍薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Takeda Pharmaceutical、Eisai、Daewoong Pharmaceutical、Allergan、AstraZeneca plc、Valeant、Zydus、Shire）
・結論

Antiulcerant Drugs are a variety of drugs used to treat gastric and intestinal ulcers.
Some of the popularAntiulcerant Drugs currently in use are H2 receptor antagonists, gastric mucosal protective drugs, antacids and antibiotics. They can also be used as proton pump inhibitors in combination therapy for patients at risk for gastrointestinal bleeding events. Their use prevents the generation of gastric acid in the stomach and lower abdomen. The increasing incidence of heartburn and indigestion caused by hyperacidity has helped Antiulcerant Drugs play an important role in treating gastric ulcers. Some Antiulcerant Drugs are also gaining popularity in the gastrointestinal irritation treatment.

Market Analysis and Insights: Global Antiulcerant Drugs Market
The global Antiulcerant Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Antiulcerant Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Antiulcerant Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Antiulcerant Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Antiulcerant Drugs market.

Global Antiulcerant Drugs Scope and Market Size
Antiulcerant Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antiulcerant Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Proton Pump Inhibitors
H2 Receptor Antagonists
Gastric Mucosal Protective Drugs
Antibiotics
Antacids
Prostaglandin Agonists

Segment by Application
Mouth Ulcers
Stomach Ulcers
Leg Ulcer
Esophageal Ulcer
Bleeding Ulcer
Neuropathic Ulcers
Venous Stasis Ulcers
Arterial (Ischemic) Ulcers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Takeda Pharmaceutical
Eisai
Daewoong Pharmaceutical
Allergan
AstraZeneca plc
Valeant
Zydus
Shire

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiulcerant Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Proton Pump Inhibitors
1.2.3 H2 Receptor Antagonists
1.2.4 Gastric Mucosal Protective Drugs
1.2.5 Antibiotics
1.2.6 Antacids
1.2.7 Prostaglandin Agonists
1.3 Market by Application
1.3.1 Global Antiulcerant Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Mouth Ulcers
1.3.3 Stomach Ulcers
1.3.4 Leg Ulcer
1.3.5 Esophageal Ulcer
1.3.6 Bleeding Ulcer
1.3.7 Neuropathic Ulcers
1.3.8 Venous Stasis Ulcers
1.3.9 Arterial (Ischemic) Ulcers
1.3.10 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Antiulcerant Drugs Market Perspective (2016-2027)
2.2 Antiulcerant Drugs Growth Trends by Regions
2.2.1 Antiulcerant Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Antiulcerant Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Antiulcerant Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Antiulcerant Drugs Industry Dynamic
2.3.1 Antiulcerant Drugs Market Trends
2.3.2 Antiulcerant Drugs Market Drivers
2.3.3 Antiulcerant Drugs Market Challenges
2.3.4 Antiulcerant Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Antiulcerant Drugs Players by Revenue
3.1.1 Global Top Antiulcerant Drugs Players by Revenue (2016-2021)
3.1.2 Global Antiulcerant Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Antiulcerant Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Antiulcerant Drugs Revenue
3.4 Global Antiulcerant Drugs Market Concentration Ratio
3.4.1 Global Antiulcerant Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiulcerant Drugs Revenue in 2020
3.5 Antiulcerant Drugs Key Players Head office and Area Served
3.6 Key Players Antiulcerant Drugs Product Solution and Service
3.7 Date of Enter into Antiulcerant Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Antiulcerant Drugs Breakdown Data by Type
4.1 Global Antiulcerant Drugs Historic Market Size by Type (2016-2021)
4.2 Global Antiulcerant Drugs Forecasted Market Size by Type (2022-2027)

5 Antiulcerant Drugs Breakdown Data by Application
5.1 Global Antiulcerant Drugs Historic Market Size by Application (2016-2021)
5.2 Global Antiulcerant Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Antiulcerant Drugs Market Size (2016-2027)
6.2 North America Antiulcerant Drugs Market Size by Type
6.2.1 North America Antiulcerant Drugs Market Size by Type (2016-2021)
6.2.2 North America Antiulcerant Drugs Market Size by Type (2022-2027)
6.2.3 North America Antiulcerant Drugs Market Size by Type (2016-2027)
6.3 North America Antiulcerant Drugs Market Size by Application
6.3.1 North America Antiulcerant Drugs Market Size by Application (2016-2021)
6.3.2 North America Antiulcerant Drugs Market Size by Application (2022-2027)
6.3.3 North America Antiulcerant Drugs Market Size by Application (2016-2027)
6.4 North America Antiulcerant Drugs Market Size by Country
6.4.1 North America Antiulcerant Drugs Market Size by Country (2016-2021)
6.4.2 North America Antiulcerant Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Antiulcerant Drugs Market Size (2016-2027)
7.2 Europe Antiulcerant Drugs Market Size by Type
7.2.1 Europe Antiulcerant Drugs Market Size by Type (2016-2021)
7.2.2 Europe Antiulcerant Drugs Market Size by Type (2022-2027)
7.2.3 Europe Antiulcerant Drugs Market Size by Type (2016-2027)
7.3 Europe Antiulcerant Drugs Market Size by Application
7.3.1 Europe Antiulcerant Drugs Market Size by Application (2016-2021)
7.3.2 Europe Antiulcerant Drugs Market Size by Application (2022-2027)
7.3.3 Europe Antiulcerant Drugs Market Size by Application (2016-2027)
7.4 Europe Antiulcerant Drugs Market Size by Country
7.4.1 Europe Antiulcerant Drugs Market Size by Country (2016-2021)
7.4.2 Europe Antiulcerant Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Antiulcerant Drugs Market Size (2016-2027)
8.2 Asia-Pacific Antiulcerant Drugs Market Size by Type
8.2.1 Asia-Pacific Antiulcerant Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Antiulcerant Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Antiulcerant Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Antiulcerant Drugs Market Size by Application
8.3.1 Asia-Pacific Antiulcerant Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Antiulcerant Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Antiulcerant Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Antiulcerant Drugs Market Size by Region
8.4.1 Asia-Pacific Antiulcerant Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Antiulcerant Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Antiulcerant Drugs Market Size (2016-2027)
9.2 Latin America Antiulcerant Drugs Market Size by Type
9.2.1 Latin America Antiulcerant Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Antiulcerant Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Antiulcerant Drugs Market Size by Type (2016-2027)
9.3 Latin America Antiulcerant Drugs Market Size by Application
9.3.1 Latin America Antiulcerant Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Antiulcerant Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Antiulcerant Drugs Market Size by Application (2016-2027)
9.4 Latin America Antiulcerant Drugs Market Size by Country
9.4.1 Latin America Antiulcerant Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Antiulcerant Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Antiulcerant Drugs Market Size (2016-2027)
10.2 Middle East & Africa Antiulcerant Drugs Market Size by Type
10.2.1 Middle East & Africa Antiulcerant Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Antiulcerant Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Antiulcerant Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Antiulcerant Drugs Market Size by Application
10.3.1 Middle East & Africa Antiulcerant Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Antiulcerant Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Antiulcerant Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Antiulcerant Drugs Market Size by Country
10.4.1 Middle East & Africa Antiulcerant Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Antiulcerant Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Takeda Pharmaceutical
11.1.1 Takeda Pharmaceutical Company Details
11.1.2 Takeda Pharmaceutical Business Overview
11.1.3 Takeda Pharmaceutical Antiulcerant Drugs Introduction
11.1.4 Takeda Pharmaceutical Revenue in Antiulcerant Drugs Business (2016-2021)
11.1.5 Takeda Pharmaceutical Recent Development
11.2 Eisai
11.2.1 Eisai Company Details
11.2.2 Eisai Business Overview
11.2.3 Eisai Antiulcerant Drugs Introduction
11.2.4 Eisai Revenue in Antiulcerant Drugs Business (2016-2021)
11.2.5 Eisai Recent Development
11.3 Daewoong Pharmaceutical
11.3.1 Daewoong Pharmaceutical Company Details
11.3.2 Daewoong Pharmaceutical Business Overview
11.3.3 Daewoong Pharmaceutical Antiulcerant Drugs Introduction
11.3.4 Daewoong Pharmaceutical Revenue in Antiulcerant Drugs Business (2016-2021)
11.3.5 Daewoong Pharmaceutical Recent Development
11.4 Allergan
11.4.1 Allergan Company Details
11.4.2 Allergan Business Overview
11.4.3 Allergan Antiulcerant Drugs Introduction
11.4.4 Allergan Revenue in Antiulcerant Drugs Business (2016-2021)
11.4.5 Allergan Recent Development
11.5 AstraZeneca plc
11.5.1 AstraZeneca plc Company Details
11.5.2 AstraZeneca plc Business Overview
11.5.3 AstraZeneca plc Antiulcerant Drugs Introduction
11.5.4 AstraZeneca plc Revenue in Antiulcerant Drugs Business (2016-2021)
11.5.5 AstraZeneca plc Recent Development
11.6 Valeant
11.6.1 Valeant Company Details
11.6.2 Valeant Business Overview
11.6.3 Valeant Antiulcerant Drugs Introduction
11.6.4 Valeant Revenue in Antiulcerant Drugs Business (2016-2021)
11.6.5 Valeant Recent Development
11.7 Zydus
11.7.1 Zydus Company Details
11.7.2 Zydus Business Overview
11.7.3 Zydus Antiulcerant Drugs Introduction
11.7.4 Zydus Revenue in Antiulcerant Drugs Business (2016-2021)
11.7.5 Zydus Recent Development
11.8 Shire
11.8.1 Shire Company Details
11.8.2 Shire Business Overview
11.8.3 Shire Antiulcerant Drugs Introduction
11.8.4 Shire Revenue in Antiulcerant Drugs Business (2016-2021)
11.8.5 Shire Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Antiulcerant Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Proton Pump Inhibitors
Table 3. Key Players of H2 Receptor Antagonists
Table 4. Key Players of Gastric Mucosal Protective Drugs
Table 5. Key Players of Antibiotics
Table 6. Key Players of Antacids
Table 7. Key Players of Prostaglandin Agonists
Table 8. Global Antiulcerant Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Antiulcerant Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Antiulcerant Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Antiulcerant Drugs Market Share by Regions (2016-2021)
Table 12. Global Antiulcerant Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Antiulcerant Drugs Market Share by Regions (2022-2027)
Table 14. Antiulcerant Drugs Market Trends
Table 15. Antiulcerant Drugs Market Drivers
Table 16. Antiulcerant Drugs Market Challenges
Table 17. Antiulcerant Drugs Market Restraints
Table 18. Global Antiulcerant Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Antiulcerant Drugs Market Share by Players (2016-2021)
Table 20. Global Top Antiulcerant Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiulcerant Drugs as of 2020)
Table 21. Ranking of Global Top Antiulcerant Drugs Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Antiulcerant Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Antiulcerant Drugs Product Solution and Service
Table 25. Date of Enter into Antiulcerant Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Antiulcerant Drugs Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Antiulcerant Drugs Revenue Market Share by Type (2016-2021)
Table 29. Global Antiulcerant Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Antiulcerant Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Antiulcerant Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Antiulcerant Drugs Revenue Market Share by Application (2016-2021)
Table 33. Global Antiulcerant Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Antiulcerant Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Antiulcerant Drugs Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Antiulcerant Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Antiulcerant Drugs Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Antiulcerant Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Antiulcerant Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Antiulcerant Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Antiulcerant Drugs Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Antiulcerant Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Antiulcerant Drugs Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Antiulcerant Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Antiulcerant Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Antiulcerant Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Antiulcerant Drugs Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Antiulcerant Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Antiulcerant Drugs Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Antiulcerant Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Antiulcerant Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Antiulcerant Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Antiulcerant Drugs Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Antiulcerant Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Antiulcerant Drugs Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Antiulcerant Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Antiulcerant Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Antiulcerant Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Antiulcerant Drugs Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Antiulcerant Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Antiulcerant Drugs Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Antiulcerant Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Antiulcerant Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Antiulcerant Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 65. Takeda Pharmaceutical Company Details
Table 66. Takeda Pharmaceutical Business Overview
Table 67. Takeda Pharmaceutical Antiulcerant Drugs Product
Table 68. Takeda Pharmaceutical Revenue in Antiulcerant Drugs Business (2016-2021) & (US$ Million)
Table 69. Takeda Pharmaceutical Recent Development
Table 70. Eisai Company Details
Table 71. Eisai Business Overview
Table 72. Eisai Antiulcerant Drugs Product
Table 73. Eisai Revenue in Antiulcerant Drugs Business (2016-2021) & (US$ Million)
Table 74. Eisai Recent Development
Table 75. Daewoong Pharmaceutical Company Details
Table 76. Daewoong Pharmaceutical Business Overview
Table 77. Daewoong Pharmaceutical Antiulcerant Drugs Product
Table 78. Daewoong Pharmaceutical Revenue in Antiulcerant Drugs Business (2016-2021) & (US$ Million)
Table 79. Daewoong Pharmaceutical Recent Development
Table 80. Allergan Company Details
Table 81. Allergan Business Overview
Table 82. Allergan Antiulcerant Drugs Product
Table 83. Allergan Revenue in Antiulcerant Drugs Business (2016-2021) & (US$ Million)
Table 84. Allergan Recent Development
Table 85. AstraZeneca plc Company Details
Table 86. AstraZeneca plc Business Overview
Table 87. AstraZeneca plc Antiulcerant Drugs Product
Table 88. AstraZeneca plc Revenue in Antiulcerant Drugs Business (2016-2021) & (US$ Million)
Table 89. AstraZeneca plc Recent Development
Table 90. Valeant Company Details
Table 91. Valeant Business Overview
Table 92. Valeant Antiulcerant Drugs Product
Table 93. Valeant Revenue in Antiulcerant Drugs Business (2016-2021) & (US$ Million)
Table 94. Valeant Recent Development
Table 95. Zydus Company Details
Table 96. Zydus Business Overview
Table 97. Zydus Antiulcerant Drugs Product
Table 98. Zydus Revenue in Antiulcerant Drugs Business (2016-2021) & (US$ Million)
Table 99. Zydus Recent Development
Table 100. Shire Company Details
Table 101. Shire Business Overview
Table 102. Shire Revenue in Antiulcerant Drugs Business (2016-2021) & (US$ Million)
Table 103. Shire Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antiulcerant Drugs Market Share by Type: 2020 VS 2027
Figure 2. Proton Pump Inhibitors Features
Figure 3. H2 Receptor Antagonists Features
Figure 4. Gastric Mucosal Protective Drugs Features
Figure 5. Antibiotics Features
Figure 6. Antacids Features
Figure 7. Prostaglandin Agonists Features
Figure 8. Global Antiulcerant Drugs Market Share by Application: 2020 VS 2027
Figure 9. Mouth Ulcers Case Studies
Figure 10. Stomach Ulcers Case Studies
Figure 11. Leg Ulcer Case Studies
Figure 12. Esophageal Ulcer Case Studies
Figure 13. Bleeding Ulcer Case Studies
Figure 14. Neuropathic Ulcers Case Studies
Figure 15. Venous Stasis Ulcers Case Studies
Figure 16. Arterial (Ischemic) Ulcers Case Studies
Figure 17. Others Case Studies
Figure 18. Antiulcerant Drugs Report Years Considered
Figure 19. Global Antiulcerant Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 20. Global Antiulcerant Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 21. Global Antiulcerant Drugs Market Share by Regions: 2020 VS 2027
Figure 22. Global Antiulcerant Drugs Market Share by Regions (2022-2027)
Figure 23. Global Antiulcerant Drugs Market Share by Players in 2020
Figure 24. Global Top Antiulcerant Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiulcerant Drugs as of 2020
Figure 25. The Top 10 and 5 Players Market Share by Antiulcerant Drugs Revenue in 2020
Figure 26. Global Antiulcerant Drugs Revenue Market Share by Type (2016-2021)
Figure 27. Global Antiulcerant Drugs Revenue Market Share by Type (2022-2027)
Figure 28. North America Antiulcerant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. North America Antiulcerant Drugs Market Share by Type (2016-2027)
Figure 30. North America Antiulcerant Drugs Market Share by Application (2016-2027)
Figure 31. North America Antiulcerant Drugs Market Share by Country (2016-2027)
Figure 32. United States Antiulcerant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Canada Antiulcerant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Europe Antiulcerant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Europe Antiulcerant Drugs Market Share by Type (2016-2027)
Figure 36. Europe Antiulcerant Drugs Market Share by Application (2016-2027)
Figure 37. Europe Antiulcerant Drugs Market Share by Country (2016-2027)
Figure 38. Germany Antiulcerant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. France Antiulcerant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. U.K. Antiulcerant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Italy Antiulcerant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Russia Antiulcerant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Nordic Antiulcerant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Asia-Pacific Antiulcerant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Asia-Pacific Antiulcerant Drugs Market Share by Type (2016-2027)
Figure 46. Asia-Pacific Antiulcerant Drugs Market Share by Application (2016-2027)
Figure 47. Asia-Pacific Antiulcerant Drugs Market Share by Region (2016-2027)
Figure 48. China Antiulcerant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Japan Antiulcerant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. South Korea Antiulcerant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Southeast Asia Antiulcerant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. India Antiulcerant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Australia Antiulcerant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Latin America Antiulcerant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Latin America Antiulcerant Drugs Market Share by Type (2016-2027)
Figure 56. Latin America Antiulcerant Drugs Market Share by Application (2016-2027)
Figure 57. Latin America Antiulcerant Drugs Market Share by Country (2016-2027)
Figure 58. Mexico Antiulcerant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Brazil Antiulcerant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Middle East & Africa Antiulcerant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Middle East & Africa Antiulcerant Drugs Market Share by Type (2016-2027)
Figure 62. Middle East & Africa Antiulcerant Drugs Market Share by Application (2016-2027)
Figure 63. Middle East & Africa Antiulcerant Drugs Market Share by Country (2016-2027)
Figure 64. Turkey Antiulcerant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 65. Saudi Arabia Antiulcerant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 66. UAE Antiulcerant Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 67. Takeda Pharmaceutical Revenue Growth Rate in Antiulcerant Drugs Business (2016-2021)
Figure 68. Eisai Revenue Growth Rate in Antiulcerant Drugs Business (2016-2021)
Figure 69. Daewoong Pharmaceutical Revenue Growth Rate in Antiulcerant Drugs Business (2016-2021)
Figure 70. Allergan Revenue Growth Rate in Antiulcerant Drugs Business (2016-2021)
Figure 71. AstraZeneca plc Revenue Growth Rate in Antiulcerant Drugs Business (2016-2021)
Figure 72. Valeant Revenue Growth Rate in Antiulcerant Drugs Business (2016-2021)
Figure 73. Zydus Revenue Growth Rate in Antiulcerant Drugs Business (2016-2021)
Figure 74. Shire Revenue Growth Rate in Antiulcerant Drugs Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed

以下、関連資料のご紹介

世界の掻痒治療薬市場規模・現状・予測（2021年-2027年）

Global Pruritus Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5973 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、掻痒治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（局所、経口、非経口）、用途別市場規模（血液性そう痒症、腫瘍性そう痒症、腎性そう痒症、内分泌性そう痒症、胆汁うっ滞性そう痒症）、主要地域別市場規...

世界の眼瞼炎薬市場規模・現状・予測（2021年-2027年）

Global Blepharitis Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5625 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、眼瞼炎薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ステロイド、抗生物質）、用途別市場規模（単剤療法、併用薬物療法）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の高脂血症治療薬市場規模・現状・予測（2021年-2027年）

Global Hyperlipidemia Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5791 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、高脂血症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（スタチン、胆汁酸封鎖剤、コレステロール吸収阻害剤、フィブリン酸誘導体、その他）、用途別市場規模（病院、歯科クリニック）、主要地域別市場規模...

世界の気管支拡張症薬市場規模・現状・予測（2021年-2027年）

Global Bronchiectasis Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5637 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、気管支拡張症薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、去痰薬、その他）、用途別市場規模（病院、研究所、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、...

世界の起立性低血圧治療薬市場規模・現状・予測（2021年-2027年）

Global Orthostatic Hypotension Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5919 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、起立性低血圧治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ミドドリン、ノーセラ（ドロキシドパ）、フルドロコルチゾン、その他薬剤）、用途別市場規模（病院、医療研究所、クリニック、その他）、主要地...

世界の脊髄性筋萎縮症（SMA）治療薬市場規模・現状・予測（2021年-2027年）

Global Spinal Muscular Atrophy (SMA) Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4894 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、脊髄性筋萎縮症（SMA）治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、注射薬）、用途別市場規模（乳児、子供、大人）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、...

世界の抗マニア薬市場規模・現状・予測（2021年-2027年）

Global Antimania Drugs Market Size, Status and Forecast 2021-2027
QFJ1-3829 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、抗マニア薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（炭酸リチウム、その他）、用途別市場規模（子供、青少年、中年、高齢者）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界の強迫性障害治療薬市場規模・現状・予測（2021年-2027年）

Global Obsessive-Compulsive Disorder Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5903 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、強迫性障害治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（SSRI、TCA、その他）、用途別市場規模（病院、クリニック、研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のゴーシェ病（GD）治療薬市場規模・現状・予測（2021年-2027年）

Global Gaucher Disease (GD) Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5747 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、ゴーシェ病（GD）治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（酵素補充療法、基質減少療法）、用途別市場規模（非神経障害性ゴーシェ病、神経障害性ゴーシェ病）、主要地域別市場規模（北米、アメリカ...

世界の免疫性血小板減少症治療薬市場規模・現状・予測（2021年-2027年）

Global Immune Thrombocytopenia Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5797 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、免疫性血小板減少症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（トロンボポエチン受容体作動薬 (TPO-RAs)、コルチコステロイド、静脈免疫グロブリン (IVIGs)、その他薬剤）、用途別市...

消化性潰瘍治療薬のグローバル市場2021 Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. China’s anti-trust crackdown on foreign pharmaceutical companies has left many foreign investors in the healthcare industry…
口腔内潰瘍治療薬のグローバル市場調査 2019年 The global Mouth Ulcers Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Mouth Ulcers Drugs volume and value at global level, regional level and company level. From a global perspective, this r…
世界の食道がん治療薬市場規模・現状・予測（2021年-2027年） Esophageal cancer is cancer arising from the esophagus—the food pipe that runs between the throat and the stomach.Symptoms often include difficulty in swallowing and weight loss.Other symptoms may include pain when swallowing, a hoarse voice, enlarged lymph nodes ("glands") around the collarbone, a …
世界の糖尿病性潰瘍治療市場規模・現状・予測（2021年-2027年） Diabetic foot ulcer is a major complication of diabetes mellitus, and probably the major component of the diabetic foot. Market Analysis and Insights: Global Diabetic Ulcers Treatment Market The global Diabetic Ulcers Treatment market size is projected to reach US$ 9041.7 million by 2027, from US$ 6…
世界の糖尿病性足潰瘍（DFU）療法市場規模・現状・予測（2021年-2027年） Diabetic foot ulcer is a major complication of diabetes mellitus, and probably the major component of the diabetic foot. Market Analysis and Insights: Global Diabetic Foot Ulcer (DFU) Therapy Market The global Diabetic Foot Ulcer (DFU) Therapy market size is projected to reach US$ XX million by 2027…